February 11, 2025 records indicate that Representative Emily Randall filed a sale of Abbott Laboratories ABT, valued between $11,011 and $165,000. According to the February filing, the transaction ...

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Abbott Laboratories (NYSE:ABT) discovers, develops, manufactures and sells healthcare products ...

Speaking of which, we noticed some great changes in Abbott Laboratories' (NYSE:ABT) returns on capital, so let's have a look. Just to clarify if you're unsure, ROCE is a metric for evaluating how ...

Abbott Laboratories closed 2024 with an impressive 10.1% organic revenue growth, surpassing consensus estimates. This performance was particularly notable given the lower-than-expected Covid ...

Abbott Laboratories (NYSE:ABT) traded ~2% lower in the premarket on Wednesday after the diagnostics company's Q4 2024 results fell short of Street forecasts for revenue despite outperformance in ...

Emily Randall, the congresswoman representing Washington's 6th congressional district, has recently sold stocks in a range of companies, according to a congressional trade report. The transactions ...

On January 22, Abbott Laboratories published financial results for the fourth quarter of 2024, initially receiving mixed reactions from Wall Street. However, its revenue was about $10.97 billion ...

Shares of Abbott Laboratories ABT slipped 2.91% to $128.22 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.36% to 6,083 ...

The outlook and technical action suggest Abbott Laboratories (NYSE: ABT) will lead healthcare names like Johnson & Johnson (NYSE: JNJ) higher in 2025. While each produced a solid quarter ...